Benjamin Summerhays, DPM
Foot & Ankle Surgery · Columbia, MONPI 1598087413
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Elite Orthopedics, LLC at 50.0% of the total. Reporting peaked in 2024 at $6,489 and has fallen 75.6% since, to $1,584 in 2025.
Across 94 payments — averaging $285.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$13K
- Arthrex$9K
- Stryker$2K
- Linvatec Corporation$1K
- Johnson & Johnson$842
- Paragon 28, Inc.$611
- plus $681 from 4 others
Across 3 payments — averaging $2666.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$8K
What the payments were for
- Speaking & faculty fees$6,00022%
- Travel & lodging$2,5089%
- Food & beverage$4,38016%
- Education$13,97352%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 35 | $13,423 |
| Arthrex | 11 | $8,504 |
| Stryker(2 entities) | 16 | $1,716 |
| Linvatec Corporation | 6 | $1,083 |
| Johnson & Johnson | 12 | $842 |
| Paragon 28, Inc. | 3 | $611 |
| Treace Medical Concepts, Inc. | 8 | $486 |
| Bone Support Inc. | 1 | $133 |
| Biocomposites Inc | 1 | $48 |
| Pacira Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioBrace 23mm$927
- INVISION$557
- INFINITY$555
- Additive Orthopedics$546
- MOTOBAND$435
- NA$425
- HAMMERLOCK$275
- Lapiplasty System$249
- AUGMENT INJECTABLE$172
- INBONE$155
- ORTHOLOC 2 LAPIFUSE$152
- AXS INFINITY LS$152
- CERAMENTBONE VOID FILLER$133
- CERAMENT G$133
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE FIBERTAK$117
How this compares
$26,861 in reported general payments places this provider in the 85th percentile of 163 foot & ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 27 | $140 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 46 | $89 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Columbia
- Brian KleiberColumbia$84K
- Levi GauseColumbia$45K
- Kyle FialaColumbia$37K
- Kurt KrautmannColumbia$15K
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Timothy BadweyKansas City$427K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- Amar PatelLees Summit$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.